A Caltech Library Service

Vimentin filaments are assembled from a soluble precursor in avian erythroid cells

Blikstad, Ingrid and Lazarides, Elias (1983) Vimentin filaments are assembled from a soluble precursor in avian erythroid cells. Journal of Cell Biology, 96 (6). pp. 1803-1808. ISSN 0021-9525. PMCID PMC2112442. doi:10.1083/jcb.96.6.1803.

PDF - Published Version
See Usage Policy.


Use this Persistent URL to link to this item:


The synthesis and assembly of vimentin was studied in erythroid cells from 10-d-old chicken embryos. After various periods of [35S]methionine incorporation, cells were lysed in a Triton X-100-containing buffer and separated into a soluble and an insoluble (cytoskeletal) fraction. Analysis of these two fractions by two-dimensional gel electrophoresis shows that vimentin is almost exclusively present in the cytoskeletal fraction and that newly synthesized vimentin is rapidly incorporated into this fraction. However, after a short pulse-labeling period, a prominent labeled protein at the position of vimentin is present in the soluble fraction. By immunoautoradiography and immunoprecipitations with vimentin antibodies, this protein was identified as vimentin. The vimentin in the soluble fraction is not sedimented by high speed centrifugation, suggesting that it does not consist of short filaments. After different pulse-labeling periods, assembly of newly synthesized vimentin in the cytoskeletal fraction increases linearly, while the radioactivity in the soluble vimentin remains constant. During a 2-h pulse-chase period, the vimentin in the soluble fraction is chased into the cytoskeletal fraction, with a half-life of 7 min. These results suggest that in chicken embryo erythroid cells newly synthesized vimentin is rapidly assembled into filaments from a soluble precursor.

Item Type:Article
Related URLs:
URLURL TypeDescription CentralArticle
Additional Information:© 1983 by The Rockefeller University Press. Received for publication 28 December 1982, and in revised form 3 March 1983. We thank Dr. Bruce Granger for the vimentin antisera and Dr. Randal T. Moon for providing us with the immunoprecipitation protocol. We also thank Dr. Lars Carlsson and Dr. Bruce Granger for many helpful suggestions during the course of this work. This work was supported by grants from the National Institutes of Health, the National Science Foundation, and the Muscular Dystrophy Association of America. Dr. I. Blikstad was also supported by a postdoctoral fellowship from the Swedish Natural Science Research Council. Dr. E. Lazarides is a recipient of a Research Career Development Award from the National Institutes of Health.
Funding AgencyGrant Number
Muscular Dystrophy Association of AmericaUNSPECIFIED
Swedish Natural Science Research CouncilUNSPECIFIED
Issue or Number:6
PubMed Central ID:PMC2112442
Record Number:CaltechAUTHORS:BLIjcb83
Persistent URL:
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:4437
Deposited By: Lindsay Cleary
Deposited On:23 Aug 2006
Last Modified:08 Nov 2021 20:17

Repository Staff Only: item control page